Fact Sheet: ActionSeq™

The JAX ActionSeq™ test is a targeted panel of 212 cancer related genes analyzed using next-generation sequencing. The panel assesses all identified functional variants for clinical relevance, based on associations in the biomedical literature with response or resistance to FDA-approved targeted therapies. 

In this fact sheet you will find how identifying and characterizing the mutations in tumors therefore can have both diagnostic and therapeutic applications. The advent of next generation sequencing has enabled high-throughput, accurate molecular profiling across many tumor types.

Request a PDF copy